MS VLPs delivered long non-coding RNA maternally expressed gene 3 (MEG3) specifically to epidermal growth factor receptor (EGFR)-positive hepatocellular carcinoma (HCC) cell lines, without activating EGFR downstream signaling pathways. This evidence concerns the gene EGFR and hepatocellular carcinoma.